newsfilter
← Latest News
GlobeNewswire·

Angion Provides Corporate Update and Reports Third Quarter 2021 Financial Results

UNIONDALE, N.Y., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Angion Biomedica Corp (NASDAQ:ANGN), a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to address acute organ inj